Patent Assignment
Reel/Frame 034491/0663
Assignment of Assignor's Interest
Recorded: 2014-12-12
Pages: 19
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2014-12-01
Assignee
ALDERBIO HOLDINGS LLC
101 CONVENTION CENTER DRIVE, SUITE 850, LAS VEGAS, NEVADA, 89101
Covered Properties
(32)
Antibodies to Il-6 and Use Thereof
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Antagonists of Il-6 to Prevent or Treat Thrombosis
Nucleic Acids Encoding Antibodies to Il-6, and Recombinant Production of Anti-Il-6 Antibodies
Use of Anti-Il-6 Antibodies Having Specific Binding Properties to Treat Cachexia
Antibodies to Il-6 and Use Thereof
Treating Anemia Using Il-6 Antibodies Having Particular Epitopic Specificity
Application:
12/601,295 →
Publication:
US 2010/0290993
Methods of Treating or Diagnosing Conditions Associated with Elevated Il-6 Using Anti-Il-6 Antibodies or Fragments
Methods of Treating Anemia Using Anti-Il-6 Antibodies
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Nucleic Acids Encoding Anti-Il-6 Antibodies of Defined Epitopic Specificity
Methods of Reducing Crp and/or Increasing Serum Albumin in Patients in Need Using Il-6 Antibodies of Defined Epitopic Specificity
Antibodies to Il-6 and Use Thereof
Application:
13/277,390 →
Publication:
US 2012/0142900
Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity
Application:
13/298,407 →
Publication:
US 2013/0017575
Anti-Il-6 Antibodies for the Treatment of Arthritis
Anti-Il-6 Antibodies for the Treatment of Anemia
Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Application:
13/511,409 →
Publication:
US 2012/0294852
Subcutaneously Administrable Composition Containing Anti-Il-6 Antibody
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Treat Cachexia, Weakness, Fatigue , and/or Fever
Antibodies to Il-6 to Inhibit or Treat Inflammation
Antagonists of IL-6 to raise albumin and/or lower crp
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Method of Improving Patient Survivability and Quality of Life by Anti-Il-6 Antibody Administration
Antibodies to Il-6 and Use Thereof
Anti-Il-6 Antibodies for the Treatment of Psoriatic Arthritis
Application:
61/887,666 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 12, 2010
From: GARCIA-MARTINEZ, LEON; JENSEN, ANNE ELIZABETH CARVALHO; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 023763/0347 →
Corrective Assignment to Correct the Assignee's Name in Non-Us Cases Only Previously Recorded on Reel 025681 Frame 0634. Assignor(S) Hereby Confirms the Conveyance of Non-Us Rights of Patents Relating to Applications Listed in Assignment..
Nov 28, 2012
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 029372/0056 →
Assignment of Assignor's Interest
Dec 26, 2013
From: SMITH, JEFFREY T.L.; SCHATZMAN, RANDALL C; LITTON, MARK J; LATHAM, JOHN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 031848/0494 →
Corrective Assignment to Correct the the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 022155 Frame 0247. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0840 →
Corrective Assignment to Correct the Assignee's Name to Correctly Read Alder Biopharmaceuticals, Inc. Previously Recorded on Reel 022264 Frame 0501. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: SMITH, JEFFREY T.L.
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0853 →
Corrective Assignment to Correct the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 024029 Frame 0749. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0983 →
Corrective Assignment to Correct the Spelling of Inventor Anne Elisabeth Carvalho Jensen's Name Previously Recorded on Reel 023763 Frame 0347. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032231/0411 →
Assignment of Assignor's Interest
Feb 24, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032329/0931 →
Assignment of Assignor's Interest
Feb 25, 2014
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032289/0791 →
Assignment of 1/2 Interest in Non-U.S. Applications
Feb 25, 2014
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 032332/0787 →
Assignment of Assignor's Interest
Jan 16, 2015
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034777/0728 →
Change of Name
Jun 23, 2020
From: ALDER BIOPHARMACEUTICALS, INC.
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
Reel/Frame 053020/0143 →
Assignment of Assignor's Interest
Jun 23, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 053020/0205 →
Assignment of Assignor's Interest
Aug 14, 2020
From: H. LUNDBECK A/S
To: VITAERIS INC.
Reel/Frame 053496/0319 →
Change of Name
Sep 3, 2020
From: ALDER BIOPHARMACEUTICALS, INC
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
Reel/Frame 053681/0224 →
Assignment of Assignor's Interest
Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment.
Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →